Erythrocytes identify complement activation in patients with COVID-19

L K Metthew Lam1,2, John P Reilly1,2, Ann H Rux3

  • 1Division of Pulmonary, Allergy and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Summary

Erythrocytes can help diagnose complement activation in sepsis, including COVID-19. Enhanced C3b and C4d deposition on red blood cells indicates complement dysregulation, aiding precision medicine for sepsis patients.